Since it was signed into law in 2022, the health industry has been abuzz about the longer-term impact of the Inflation Reduction Act. In this episode, Jen & Mindy sit down to discuss recent headlines and developments around this landmark legislation and what Life Sciences companies should expect over the course of the next year.

For more perspective on the Inflation Reduction Act\’s impact on Life Sciences companies, check out Mindy’s article in Pharmaphorum, "Seizing the moment: The life sciences industry at the threshold of change”.

Podcast Tags: healthcare, healthcare news, life sciences, health policy, inflation reduction act, drug prices, pharmaceutical

Panel – Jen Burke, Mindy McGrath

Research & Production – Jen Burke, Mindy McGrath

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.